John Orloff
Venture Partner at Agent Capital
About
John Orloff joins Agent Capital as a Venture Partner following his role as EVP and Global Head of R&D at Alexion, where he expanded the development pipeline from three to 30 programs prior to the company's $39 billion acquisition by AstraZeneca. He previously served as Global Head of R&D and Chief Scientific Officer at Baxalta and held executive leadership roles at multiple major biopharmaceutical companies including Novartis and Merck.
Colleagues at Agent Capital
Anthony DiNatale
Vice President at Agent Capital
Bob Hombach
Industry Advisor at Agent Capital
Bob Parkinson
Industry Advisor at Agent Capital
Bruce Peacock
Operating Partner at Agent Capital
Geeta Vemuri
Managing Partner, Founder at Agent Capital
John Glasspool
Venture Partner at Agent Capital
Julie Gionfriddo
Head of Investor Relations and Fundraising at Agent Capital
Kirti Nimmala
Investment Analyst at Agent Capital